Vaginal rings, films, inserts or gels – it’s all about choice
The long tail of injectable PrEP is especially long for women
Far more people may be using PrEP than we know, HIV prevention conference hears
People with HIV can safely use immunotherapy for cancer
380,000 people on PrEP globally, mostly in the USA and Africa [updated]
Viral suppression within three months of HIV diagnosis should be a policy target, NYC officials say
Drug resistance accumulates fast in people with low but detectable viral loads, Kenyan study finds
First HIV-positive to HIV-negative liver transplant raises intriguing questions for cure research
Majority of US young adults who use drugs are not tested for hepatitis C or HIV
